Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone PCA titration followed by extended-release oral maintenance vs morphine ER for severe cancer pain
ChiCTR2500105374Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Jul 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in cancer pain and cancer comparing Hydromorphone group with Morphine group (2 arms). Primary endpoint: Average episodes of daily breakthrough pain from day 1 to day 6. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
hydromorphonemorphine
03
Conditions
cancer paincancer
Beyond the preview
Go deeper on ChiCTR2500105374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105374.